Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene (Q46147303)

From Wikidata

Jump to navigation Jump to search

scientific article published in November 2008

Language	Label	Description	Also known as
English	Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene	scientific article published in November 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

1 reference

based on heuristic

inferred from title

Andrew Tym Hattersley

9

object named as

Andrew T Hattersley

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

author name string

Thais Della Manna

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Claudilene Battistim

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Vanessa Radonsky

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Roberta D Savoldelli

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Durval Damiani

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Fernando Kok

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Ewan R Pearson

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Sian Ellard

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

André F Reis

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Arquivos Brasileiros de Endocrinologia e Metabologia

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

52

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

1350-1355

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

Long-term course of neonatal diabetes.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Aetiopathology and genetic basis of neonatal diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Neonatal diabetes mellitus: from understudy to center stage

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Activating mutations in the ABCC8 gene in neonatal diabetes mellitus

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R2

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

The G53D mutation in Kir6.2 (KCNJ11) is associated with neonatal diabetes and motor dysfunction in adulthood that is improved with sulfonylurea therapy

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Molecular basis of neonatal diabetes in Japanese patients.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Molecular analysis of ATP-sensitive K channel gating and implications for channel inhibition by ATP.

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation i

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000800024

21 January 2018

Identifiers

10.1590/S0004-27302008000800024

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19169493

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46147303&oldid=2094970022"